ArticleChemMedChem2014

Singly modified amikacin and tobramycin derivatives show increased rRNA A-site binding and higher potency against resistant bacteria.

Richard J Fair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.